<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Characteristics and quality assessment score of 10 included literatures</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Study</th>
    <th>Author
     <break/>study year
    </th>
    <th>Sample source</th>
    <th>Study period
     <break/>(
     <sup>a</sup>epidemic)
    </th>
    <th>Area</th>
    <th>Event</th>
    <th>Number</th>
    <th>Detection method</th>
    <th>Viral loads</th>
    <th>Quality score</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>p1</td>
    <td>Bierlaire2014</td>
    <td>blood collections tested prospectively and retrospectively</td>
    <td>3 months
     <sup>a</sup>
    </td>
    <td>French Polynesia</td>
    <td>42</td>
    <td>1505</td>
    <td>lab developed NAT assay</td>
    <td>2.5e3–8.1e6 copies/ ml</td>
    <td>8</td>
   </tr>
   <tr>
    <td>p2</td>
    <td>Chevalier2016</td>
    <td>blood donation screening in 2 largest blood centers</td>
    <td>4 months
     <sup>a</sup>
    </td>
    <td>Puerto Rico</td>
    <td>190</td>
    <td>21,468</td>
    <td>Cobas Zika ID-NAT</td>
    <td>NM</td>
    <td>7</td>
   </tr>
   <tr>
    <td>p3</td>
    <td>Gake2015</td>
    <td>blood donors from six sites representing eco-environments</td>
    <td>2 months</td>
    <td>Cameroon</td>
    <td>53</td>
    <td>1084</td>
    <td>Euroimmun anti-Zika NS1 IgG ELISA</td>
    <td>NM</td>
    <td>4</td>
   </tr>
   <tr>
    <td>p4</td>
    <td>Williamson2016</td>
    <td>blood donor screening at laboratories</td>
    <td>2 months</td>
    <td>several states of United State</td>
    <td>5</td>
    <td>466,834</td>
    <td>Procleix ZIKV assay, RT-PCR, CDC IgM/IgG-ELISA</td>
    <td>10
     <sup>2</sup> IU
    </td>
    <td>7</td>
   </tr>
   <tr>
    <td>p5</td>
    <td>Borena2016</td>
    <td>blood donors at randomly selected donation sites</td>
    <td>3 months</td>
    <td>Austria</td>
    <td>4</td>
    <td>1001</td>
    <td>Euroimmun anti-Zika NS1 IgM/IgG ELISA</td>
    <td>NM</td>
    <td>6</td>
   </tr>
   <tr>
    <td>p5.1</td>
    <td/>
    <td/>
    <td/>
    <td/>
    <td>0</td>
    <td>1001</td>
    <td>RealStar zika virus RT-PCR kit 1.0</td>
    <td/>
    <td/>
   </tr>
   <tr>
    <td>p6</td>
    <td>Gallian2016</td>
    <td>consecutive blood donations</td>
    <td>5 months
     <sup>a</sup>
    </td>
    <td>Martinique</td>
    <td>76</td>
    <td>4129</td>
    <td>RealStar Zika virus RT-PCR Kit_1.1</td>
    <td>2.1–6.5log10 copies/ml</td>
    <td>6</td>
   </tr>
   <tr>
    <td>p7</td>
    <td>Slavov2016</td>
    <td>volunteer blood donors</td>
    <td>7 months
     <sup>a</sup>
    </td>
    <td>Brazil</td>
    <td>37</td>
    <td>1393</td>
    <td>In-house method RNA test</td>
    <td>mean 7714 copies/ml</td>
    <td>8</td>
   </tr>
   <tr>
    <td>p8</td>
    <td>Kuehnert2016</td>
    <td>screened blood donations</td>
    <td>2 months
     <sup>a</sup>
    </td>
    <td>Puerto Rico</td>
    <td>68</td>
    <td>12,777</td>
    <td>Cobas Zika NAT assay</td>
    <td>NM</td>
    <td>4</td>
   </tr>
   <tr>
    <td>p9</td>
    <td>Adams2016</td>
    <td>screened blood donations</td>
    <td>3 months
     <sup>a</sup>
    </td>
    <td>Puerto Rico</td>
    <td>143</td>
    <td>18,163</td>
    <td>Cobas Zika NAT assay</td>
    <td>NM</td>
    <td>4</td>
   </tr>
   <tr>
    <td>p10</td>
    <td>Aubry2013</td>
    <td>volunteer blood donors</td>
    <td>27 months</td>
    <td>French Polynesia</td>
    <td>5</td>
    <td>593</td>
    <td>self-developed indirect IgG ELISA</td>
    <td>NM</td>
    <td>5</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Note: 
   <sup>a</sup>epidemic: the study period is during Zika epidemic period
  </p>
  <p>
   <italic>NM</italic> not mentioned
  </p>
 </table-wrap-foot>
</table-wrap>
